Eptifibatide-induced profound thrombocytopenia.
We report a case of profound thrombocytopenia, 2 hours following eptifibatide therapy which got reversed within 12 hours of discontinuation of eptifibatide.
Gupta
N
N
Department of Invasive Cardiology, Escorts Heart Institute and Research Centre, New Delhi.
Kapoor
R
R
Bhandari
S
S
D017023:Coronary Angiography / Q000009:adverse effects; D003907:Dexamethasone / Q000627:therapeutic use; D000077542:Eptifibatide; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage / Q000009:adverse effects*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D011379:Prognosis; D013921:Thrombocytopenia / Q000188:drug therapy / Q000209:etiology*; D016896:Treatment Outcome
D005938:Glucocorticoids; D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D003907:Dexamethasone; D000077542:Eptifibatide